Hemorrhagic Shock Treatment Market
Hemorrhagic shock is a condition resulting in tissue perfusion and inadequate delivery of oxygen and nutrients to cells. A traumatic injury can cause hemorrhagic shock if the bleeding does not stop immediately. The primary treatment for hemorrhagic shock is immediate control of the source of bleeding and fluid replacement. In CHS (controlled hemorrhagic shock), fluid replacement is prescribed to normalize hemodynamic parameters when the source of bleeding is stopped. Hemorrhagic shock is a rare condition that occurs in many gynecological or obstetric situations. In this condition, decreased blood volume results in sympathetic compensation with tachycardia, peripheral vasoconstriction, and increased myocardial contractility. This can increase the oxygen demand of the heart muscle.
Market Dynamics
With a broader understanding of the pathophysiology of hemorrhagic shock, treatment in trauma has expanded from a simple massive transfusion method to a more comprehensive management strategy of damage control resuscitation. For instance, September 1, 2022, VirTech developed a hemoglobin-based solution with blood-like oxygen carrying capacity that caught the attention of the Pentagon, the US Department of Defense. This division of the US government made a contribution of US$ 13 million that is driving toward the clinical research phase of the project. The objective is to use the product to prevent hemorrhagic shock in trauma patients and to give better survival to organs donated for transplantation.The Pentagon was interested in the possibility of the solution preventing hemorrhagic shock, a problem that affects military personnel in combat or civilians who suffer trauma, such as automobile accidents. In these cases, hemorrhagic shock is usually the main cause of death, as there is often no time for a transfusion. Research carried out so far shows that the solution, injected into the body as a temporary blood substitute, considerably increases the time available for the victim to arrive at a hospital for transfusion.
Key features of the study:
Detailed Segmentation:
Table of Contents
*Browse 47 market data tables and 43 figures on “Global Hemorrhagic Shock Treatment Market” - Global forecast to 2030
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients